Cargando…
Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
PURPOSE: Roux-en-Y gastric bypass (RYGB) surgery is currently the most efficient treatment to achieve long-term weight loss in individuals with severe obesity. This is largely attributed to marked reductions in food intake mediated in part by changes in gut-brain communication. Here, we investigated...
Autores principales: | Soeder, J. Marvin, Luthardt, Julia, Rullmann, Michael, Becker, Georg A., Hankir, Mohammed K., Patt, Marianne, Meyer, Philipp M., Schütz, Tatjana, Ding, Yu-Shin, Hilbert, Anja, Dietrich, Arne, Sabri, Osama, Hesse, Swen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490257/ https://www.ncbi.nlm.nih.gov/pubmed/34414548 http://dx.doi.org/10.1007/s11695-021-05657-7 |
Ejemplares similares
-
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022) -
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020) -
Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022) -
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020) -
Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain μ-opioid Receptor Availability in Diet-Induced Obese Male Rats
por: Hankir, Mohammed K., et al.
Publicado: (2017)